I will be speaking at a networking event for psychologists in Columbus on the proposed changes with DSM-5. Participants will be able to list changes proposed for the DSM-5; Participants will be able to describe the potential impact of DSM-5 on their clinical practice; Participants will be able to describe the underlying theory and “broad themes” behind many of the changes.
News Release:
First Central Ohio Peer Consultation Network Event
The Ohio Psychological Association Professional Practice Committee in coordination with the Central Ohio Psychological Association will be sponsoring a two hour presentation and discussion on the DSM-V proposed changes. Our goal for this event is for you to meet other psychologists to establish a Peer Consultation Network, a small group of psychologists practicing in your region. The Peer Consultation Network will enhance networking opportunities, support and discussion of issues that are relevant to your practice. Please join us to learn more about the DSM-V and to establish a community of psychologists in your region.
Date: Saturday, January 14, 2012
Time: 1 – 3 p.m.
Location: Ohio Psychological Association Central Office
395 E. Broad Street #310
Columbus, Ohio 43215
(614) 224-0034
Please RSVP to Sharla Wells-Di Gregorio, Ph.D., Chair of the OPA Professional Practice Committee by Friday, January 6 if you would like to attend. Seating is limited, so please respond ASAP.
See the News Release at the Ohio Psychological Association’s website.
Some potential discussion questions we may use include:
Each paragraph is meant to stimulate discussion around a central theme; the specific questions are less important than the ensuing discussions:
(1) The DSM is sometimes referred to as the “bible” of psychiatry. If this is true, should it be “interpreted literally?” Why and when should it be? Why and when shouldn’t it be?
(2) If you had a magic wand and could change anything about the DSM-IV what would it be and why?
(3) The DSM-5 will likely recommend the use of a number of specific rating scales. In addition, third party payors like Medicare will likely increasingly look for psychologists to report various outcomes related to their practice. With available time to see patients a constant issue, what strategies can psychologists use to best incorporate these scales in to their practice (if at all)? How do we decide which scales are best to use?
(4) At least 3 DSM-5 personality disorder work group members have published and sell personality tests. Should the authors of personality assessments be allowed to author how personality is assessed under DSM-5? How would you select DSM work group members given that their lines of research and professional identities may also be impacted by the outcome of the “expert consensus” that is arrived at by the chosen group.
(5) A dimensional conceptualization suggests that something falls on a continuum without discrete boundaries. A categorical conceptualization would imply that specific categories were 2 separate entities. Some examples of things we tend to dimensionally conceptualize, but have categorical cut offs for, are blood pressure and intelligence (IQ). DSM-5 is moving towards increasing the emphasis on dimensional conceptualizations, particularly with personality. 2 personality disorder work group members suggested that “there might be specific pharmacologic treatment implications” for personality traits such as having high neuroticism (ex: antidepressants, mood stabilizers) or low conscientiousness (ex: stimulants) Widiger, Clark & Livesley (Psychological Assessment Vol. 21, No. 3, 243–255). Should personality traits be medicated? How/”where” do we draw the line between traits and a disorder and whether they get treatment? Some concerns are that the DSM may lead to the “over-medication” of some people. Is it inherrently bad or good if more or less people become “eligible” for treatment? When would it be desirable or undesirable for someone to get treatment and/or have a diagnosis?
(6) Many of the criticisms levelled at DSM-5 also apply to DSM-IV. Can psychologists survive without the DSM? If so what would that look like? Can we throw away diagnostic labels altogether? What role could psychologists play in training others to diagnose and treat under the upcoming ICD-11?
(7) Despite vocalizing a desire to move toward a diagnostic system grounded in neuroscience and “identifiable pathophysiologic etiologies,” the DSM does not contain a listing of genetic syndromes (ex: Downs). The DSM-5 will remove Rett’s Disorder- the rationale is “Rett’s Disorder patients often have autistic symptoms for only a brief period during early childhood, so inclusion in the autism spectrum is not appropriate for most individuals. Like other disorders in the DSM, Autism Spectrum Disorder (ASD) is defined by specific sets of behaviors and not by etiology (at present) so inclusion of a specific etiologic entity, such as Rett’s Disorder is inappropriate. To ensure that etiology is indicated, where known, clinicians will be encouraged to utilize the specifier: ”“Associated with Known Medical Disorder or Genetic Condition.”” In this way, it will be possible to indicate that a child with ASD has Fragile X syndrome, Tuberous Sclerosis, 22q deletion, etc.” The DSM-5 has proposed to include Sleep Apnea, Somatic Symptom Disorders, Language & Tic disorders, etc. Where do the boundaries of what should be included in the DSM end and begin? What should be considered in arriving at this?
(8) What is in a name? Would Aspergers by any other name smell as sweet to parents? What should impact the names of diagnoses and name changes such as Mental Retardation to Intellectual Developmental Disorder?
Thanks again for your interest in PsychContinuingEd.com